Results 151 to 160 of about 214,511 (232)

Evaluation of Posaconazole Therapeutic Drug Monitoring for Antifungal Prophylaxis in Hematology Patients at a Tertiary Referral Center. [PDF]

Ther Drug Monit
Ashok A, Fernando S, Lee SJ, Coutsouvelis J, Pai Mangalore R, Morrissey CO.   +5 more
europepmc   +1 more source

Liver Transplantation Without Systemic Antifungal Prophylaxis-An Exceptional Perspective from a Single Center Experience. [PDF]

J Clin Med
Moral K, Kabaçam G, Atlı M, Cindoruk M, Bayındır Y, Sardan Y, Karademir S.   +6 more
europepmc   +1 more source

Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin. [PDF]

J Clin Med
Atas U, Iltar U, Yucel OK, Salur H, Bilek MC, Ustabas T, Candan O, Korkmaz G, Kucukyurt S, Tiglioglu P, Yigit Kaya S, Deveci B, Tekinalp A, Ciftciler R, Senturk Yikilmaz A, Elibol T, Toptas T, Gunes AK, Sevindik OG, Kaynar L, Saba R, Atagunduz I, Ozet G, Karakus V, Salim O, Kurtoglu E, Undar L.   +26 more
europepmc   +1 more source

Comparative study of liposomal amphotericin B, posaconazole, and micafungin for primary antifungal prophylaxis in pediatric patients with acute leukemia. [PDF]

J Cancer Res Clin Oncol
Gottschlich AS, Ernst J, Milde T, Gruhn B.   +3 more
europepmc   +1 more source

Correction: Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC. [PDF]

Infection
Salmanton-García J, Giacinta A, Giannella M, Vena A, Muñoz P, Cornely OA, Valerio M.   +6 more
europepmc   +1 more source

Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center. [PDF]

Cancers (Basel)
Grimaldi F, Memoli M, Avilia S, Causa C, Giannattasio ML, Conversano I, Lisi D, D'Angelo D, Iannotta R, Schiano Moriello N, Viceconte G, Zappulo E, Gentile I, Picardi M, Pane F.   +14 more
europepmc   +1 more source

Shifting Paradigms in Antifungal Prophylaxis and Their Effects on Candidemia Outcomes in Hematological Malignancies: A 14-Year Experience from a Single Tertiary Center. [PDF]

J Fungi (Basel)
Hunutlu FÇ, Özkalemkaş F, Ener B, Demirayak D, Çalışır B, Öztop H, Pınar İE, Gürsoy V, Ersal T, Koca TG, Akalın EH, Özkocaman V.   +11 more
europepmc   +1 more source

Antifungal prophylaxis in high-risk patients with hematologic malignancy: a comparison of practice and guidelines in Türkiye. [PDF]

Turk J Med Sci
Güzel Tunçcan Ö, Çağirgan S, Özdoğu H, Civriz Bozdağ S, Vural F, Pehlivan M, Beköz HS, Esen Y, Koç T, Gilik P, Şenol E.   +10 more
europepmc   +1 more source

Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC. [PDF]

Infection
Salmanton-García J, Giacinta A, Giannella M, Vena A, Muñoz P, Cornely OA, Valerio M.   +6 more
europepmc   +1 more source

Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). [PDF]

Leukemia
Pagano L, Maschmeyer G, Lamoth F, Blennow O, Xhaard A, Spadea M, Busca A, Cordonnier C, Maertens J, ECIL.   +9 more
europepmc   +1 more source